The Differential Levels of Inflammatory Cytokines and BDNF among Bipolar Spectrum Disorders
- PMID: 26865313
- PMCID: PMC5006191
- DOI: 10.1093/ijnp/pyw012
The Differential Levels of Inflammatory Cytokines and BDNF among Bipolar Spectrum Disorders
Abstract
Objective: Emerging evidence suggests that inflammation and neurodegeneration underlies bipolar disorder. To investigate biological markers of cytokines and brain-derived neurotrophic factor between bipolar I, bipolar II, and other specified bipolar disorder with short duration hypomania may support the association with inflammatory dysregulation and bipolar disorder and, more specifically, provide evidence for other specified bipolar disorder with short duration hypomania patients were similar to bipolar II disorder patients from a biological marker perspective.
Methods: We enrolled patients with bipolar I disorder (n=234), bipolar II disorder (n=260), other specified bipolar disorder with short duration hypomania (n=243), and healthy controls (n=140). Their clinical symptoms were rated using the Hamilton Depression Rating Scale and Young Mania Rating Scale. Inflammatory cytokine (tumor necrosis factor-α, C-reactive protein, transforming growth factor-β1, and interleukin-8) and brain-derived neurotrophic factor levels were measured in each group. Multivariate analysis of covariance and linear regression controlled for possible confounders were used to compare cytokine and brain-derived neurotrophic factor levels among the groups.
Results: Multivariate analysis of covariance adjusted for age and sex and a main effect of diagnosis was significant (P<.001). Three of the 5 measured biomarkers (tumor necrosis factor-α, transforming growth factor-β1, and interleukin-8) were significantly (P=.006, .01, and <.001) higher in all bipolar disorder patients than in controls. Moreover, covarying for multiple associated confounders showed that bipolar I disorder patients had significantly higher IL-8 levels than did bipolar II disorder and other specified bipolar disorder with short duration hypomania patients in multivariate analysis of covariance (P=.03) and linear regression (P=.02) analyses. Biomarkers differences between bipolar II disorder and other specified bipolar disorder with short duration hypomania patients were nonsignificant.
Conclusion: The immunological disturbance along the bipolar spectrum was most severe in bipolar I disorder patients. Other specified bipolar disorder with short duration hypomania patients and bipolar II disorder patients did not differ in these biological markers.
Keywords: BDNF; bipolar I disorder; bipolar II disorder; bipolar spectrum disorder; cytokines; subthreshold bipolarity.
© The Author 2016. Published by Oxford University Press on behalf of CINP.
Figures
Similar articles
-
Cytokines, brain-derived neurotrophic factor and C-reactive protein in bipolar I disorder - Results from a prospective study.J Affect Disord. 2016 Jun;197:167-74. doi: 10.1016/j.jad.2016.03.040. Epub 2016 Mar 10. J Affect Disord. 2016. PMID: 26994434
-
Comparing clinical responses and the biomarkers of BDNF and cytokines between subthreshold bipolar disorder and bipolar II disorder.Sci Rep. 2016 Jun 7;6:27431. doi: 10.1038/srep27431. Sci Rep. 2016. PMID: 27270858 Free PMC article. Clinical Trial.
-
Shortening of telomere length may be associated with inflammatory cytokine levels in patients with bipolar disorder.J Affect Disord. 2024 Nov 15;365:155-161. doi: 10.1016/j.jad.2024.08.084. Epub 2024 Aug 15. J Affect Disord. 2024. PMID: 39153550
-
Neurotrophins, cytokines, oxidative stress mediators and mood state in bipolar disorder: systematic review and meta-analyses.Br J Psychiatry. 2018 Sep;213(3):514-525. doi: 10.1192/bjp.2018.144. Br J Psychiatry. 2018. PMID: 30113291 Free PMC article.
-
Bipolar II disorder : epidemiology, diagnosis and management.CNS Drugs. 2007;21(9):727-40. doi: 10.2165/00023210-200721090-00003. CNS Drugs. 2007. PMID: 17696573 Review.
Cited by
-
Monoclonal antibody precision therapy targeting inflammation for bipolar disorder: a narrative review.Ther Adv Psychopharmacol. 2024 Feb 6;14:20451253241227772. doi: 10.1177/20451253241227772. eCollection 2024. Ther Adv Psychopharmacol. 2024. PMID: 38322010 Free PMC article. Review.
-
Add-On Memantine Treatment for Bipolar II Disorder Comorbid with Alcohol Dependence: A 12-Week Follow-Up Study.Alcohol Clin Exp Res. 2018 Jun;42(6):1044-1050. doi: 10.1111/acer.13640. Epub 2018 May 17. Alcohol Clin Exp Res. 2018. PMID: 29656414 Free PMC article. Clinical Trial.
-
How to treat major depressive disorder with shorter-duration hypomanic episodes? A case report.Front Psychiatry. 2024 Jul 15;15:1411882. doi: 10.3389/fpsyt.2024.1411882. eCollection 2024. Front Psychiatry. 2024. PMID: 39077629 Free PMC article.
-
IL-8 (CXCL8) Correlations with Psychoneuroimmunological Processes and Neuropsychiatric Conditions.J Pers Med. 2024 May 3;14(5):488. doi: 10.3390/jpm14050488. J Pers Med. 2024. PMID: 38793070 Free PMC article. Review.
-
Inflammation Markers in Patients with Bipolar Disorder Who Have Committed Offenses and Their Relationship with Criminal Behavior.Medicina (Kaunas). 2023 Sep 27;59(10):1725. doi: 10.3390/medicina59101725. Medicina (Kaunas). 2023. PMID: 37893443 Free PMC article.
References
-
- Akiskal HS, Benazzi F. (2003) Family history validation of the bipolar nature of depressive mixed states. J Affect Disord 73:113–122. - PubMed
-
- Akiskal HS, Bourgeois ML, Angst J, Post R, Moller H, Hirschfeld R. (2000) Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders. J Affect Disord 59 Suppl 1:S5–S30. - PubMed
-
- Akiskal HS, Djenderedjian AM, Rosenthal RH, Khani MK. (1977) Cyclothymic disorder: validating criteria for inclusion in the bipolar affective group. Am J Psychiatry 134:1227–1233. - PubMed
-
- Akiskal HS, Rosenthal RH, Rosenthal TL, Kashgarian M, Khani MK, Puzantian VR. (1979) Differentiation of primary affective illness from situational, symptomatic, and secondary depressions. Arch Gen Psychiatry 36:635–643. - PubMed
-
- Angst J. (1998) The emerging epidemiology of hypomania and bipolar II disorder. J Affect Disord 50:143–151. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials